12 October 2018
A new test that predicts with almost 100 per cent accuracy that a pregnant woman will not develop pre-eclampsia within the following seven days has been given the green light to be used as standard clinical practice in one of the UK’s biggest acute hospital trusts.
10 October 2018
Positive results of the world’s first gene therapy trial for a genetic cause of blindness known as choroideremia have been reported in Nature Medicine.
10 October 2018
Caristo Diagnostics, an Oxford University spinout company, has been launched to commercialise a new coronary CT image analysis technology that can flag patients at risk of deadly heart attacks years before they occur.
5 October 2018
Subsidiaries of the Oxford University spinout, OxStem Immuno and OxStem Beta, will draw on research from the institution.
6 September 2018
Oxford’s cutting-edge work in AI techniques that promise to transform healthcare has been showcased on BBC Radio 4’s Today programme.
6 August 2018
Experts at Oxford are teaming up with leading figures from industry to advance development of a gene therapy for cystic fibrosis.
4 July 2018
Interactive workshop with Pfizer gives Oxford’s Industry Fellows the opportunity to put into action the Drug Discovery & Development Process
19 June 2018
The app designed by researchers at the Department of Psychiatry to slow down negative thoughts of people with paranoia appeared on the BBC's The One Show. They revealed how one of the first users, Angie, is benefiting from this innovative approach.
6 June 2018
Business Secretary Greg Clark has today launched the £103m Rosalind Franklin Institute (RFI), a national centre of excellence that will harness disruptive technologies such as AI and robotics to improve dramatically our understanding of biology.
19 April 2018
Preserving livers at body temperature has been shown to improve transplant success and to increase the number of viable donor livers available for transplant, which could lead to shorter waiting lists for patients and lower mortality rates.
12 April 2018
Oxford is to take part in three new government-funded projects designed to help universities collaborate with each other, and with external organisations, to boost research commercialisation.
3 April 2018
Brainomix, a medical imaging company using artificial intelligence (AI) for the fast diagnosis and treatment of stroke victims, has attracted £7m ($9.8m) of investment to bring its software to the global healthcare market. The company was spun out from Oxford University research.
13 March 2018
The march towards replacing animals in drug testing with computer simulations has made another significant step forward, with the development of new software which can predict the possible cardiac side effects of taking a new drug.
12 March 2018
Woodford Investment Management leads round into OxSyBio, the second Oxford University spinout from Oxford Nanopore founder Hagan Bayley